Introduction {#s1}
============

The multiple Wnt signaling--related pathways are crucial to various developmental processes ([@bib27]; [@bib1]). By regulating the cellular β-catenin level, canonical Wnt signaling controls cell fate, while non-canonical Wnt signaling plays a key role in controlling convergent extension (CE) and polarized cellular orientation. Dishevelled (Dvl, or Dsh in *Drosophila*), a key component of both Wnt signaling pathways, relays Wnt signals downstream from the membrane-bound Wnt receptor Frizzled (Fz) ([@bib30]; [@bib45]; [@bib2]; [@bib51]; [@bib31]; [@bib49]; [@bib34]; [@bib38]). While Dvl mediates both canonical and non-canonical Wnt signals, different pathways diverge at this point. Therefore, Dvl has been described as the 'policeman' at the intersection who directs different Wnt signals in different directions ([@bib4]). However, the mechanism by which Dvl relays Wnt signals from Fz to different downstream components is not well understood.

Dvl contains highly conserved DIX, PDZ, and DEP domains and a highly conserved extreme C-terminus ([Figure 1](#fig1){ref-type="fig"}) ([@bib50]; [@bib48]). The PDZ and DIX domains are reported to be involved in canonical Wnt signaling, while the PDZ and DEP domains play a crucial role in non-canonical Wnt signaling ([@bib42]; [@bib2]; [@bib5]; [@bib25]; [@bib29]; [@bib52]; [@bib13]). The central PDZ domain not only participates in both pathways but also binds directly to the membrane-bound Wnt receptor Fz ([@bib51]). Many Wnt signaling regulators have been reported to mediate the different Wnt signaling pathways by interacting directly with the PDZ domain of Dvl ([@bib50]; [@bib48]; [@bib14]). Notably, in most species the extreme C-terminus of Dvl resembles a class III PDZ-binding motif (E/D-X-Ф, where Ф represents hydrophobic residues such as F, I, L, M, or V), while that of Dsh resembles a class II PDZ-binding motif (Ф-X-Ф) ([Figure 1](#fig1){ref-type="fig"}) ([@bib46]; [@bib24]). Because these two motifs suggest the possibility of intramolecular binding, we hypothesized that the C-terminus of Dvl/Dsh binds intrinsically to the Dvl PDZ domain.10.7554/eLife.08142.003Figure 1.The C-terminal tail of Dishevelled (Dvl) is a PDZ domain binding motif.Sequence alignment of the C-terminus of Dvl/Dsh from selected species ([@bib48]), showing residue numbers.**DOI:** [http://dx.doi.org/10.7554/eLife.08142.003](10.7554/eLife.08142.003)

Here we use biophysical methods to investigate the interaction of the Dvl extreme C-terminus with the Dvl PDZ domain and demonstrate that Dvl adopts a closed conformation. We also show, in a *Xenopus* model, that disruption of this intramolecular interaction activates Jun N-terminal kinase (JNK) and enhances the CE phenotype associated with activation of non-canonical Wnt signaling. Further, we demonstrate that a Dvl PDZ-binding peptide or small molecule that inhibits canonical β-catenin signaling enhances JNK activity by releasing the Dvl C-terminus from its autoinhibitory closed conformation.

Results {#s2}
=======

The Dvl C-terminus and PDZ domain directly interact {#s2-1}
---------------------------------------------------

After our initial pull-down test indicated that Dvl C-terminus might interact with the Dvl PDZ domain, we decided to use two different biophysical assays to determine the binding affinity of the Dvl PDZ domain for the Dvl-C peptide and for a peptide derived from the C-terminus of *Drosophila* Dsh ('Dsh-C peptide'). We first used a competitive binding assay. Binding of the PDZ domain to a fluorescently-labeled peptide (Rox-DprC) derived from the C-terminus of Dapper (Dpr), a known binding partner of the Dvl PDZ domain ([@bib8]), was monitored by fluorescence polarization. Both Dvl-C and Dsh-C peptides competitively inhibited the interaction of Rox-DprC with the Dvl-1 PDZ domain ([Figure 2](#fig2){ref-type="fig"}), indicating that the three peptides competed for the same binding site on the PDZ domain. The inhibition constants (K~I~) calculated from two independent experiments (12.3 ± 7.8 μM for the Dvl-C peptide and 26.8 ± 8.4 μM for the Dsh-C peptide) were similar to the binding affinity of Rox-DprC to the PDZ domain (K~D~ ∼ 7.9 ± 0.9 μM) ([@bib22], [@bib23]). We then measured the binding between Dvl-C and the Dvl-1 PDZ domain by isothermal titration calorimetry (ITC) ([Figure 3](#fig3){ref-type="fig"}) and obtained a K~D~ of 7.0 ± 0.7 μM, which is consistent with the K~I~ value observed in the fluorescence study.10.7554/eLife.08142.004Figure 2.Competitive binding experiments.The K~D~ value of the fluorescence-labeled Dapper (Dpr)-derived peptide Rox-DprC was obtained by plotting 1/ΔmP vs 1/\[PDZ\], where ΔmP is the fluorescence polarization change (×1000) of Rox-DprC and \[PDZ\] is the concentration of the PDZ domain of Dvl. The K~I~ values of the Dvl-C and Dsh-C peptides were obtained by using the equation K~D~^app^ = (K~D~/(1 + \[I\]/K~I~)).**DOI:** [http://dx.doi.org/10.7554/eLife.08142.004](10.7554/eLife.08142.004)10.7554/eLife.08142.005Figure 3.Isothermal titration calorimetry experiment.The MicroCal Auto-iTC-200 was used to obtain the binding affinity of Dvl-C peptide and Dvl PDZ protein in 50 mM phosphate buffer. The concentration of Dvl-C peptide in the syringe was 1.05 mM and the concentration of Dvl PDZ domain in the cell was 0.114 mM. The K~D~ value was averaged from two independent experiments at 25°C.**DOI:** [http://dx.doi.org/10.7554/eLife.08142.005](10.7554/eLife.08142.005)

Structural analysis of the Dvl PDZ domain in complex with the Dvl C-terminus {#s2-2}
----------------------------------------------------------------------------

We next conducted NMR chemical shift perturbation studies ([@bib51]). Unlabeled Dvl-C and Dsh-C peptides were repetitively titrated into a solution of ^15^N-labeled Dvl-1 PDZ domain. During these titrations, the NMR resonance of the residues in the PDZ domain\'s peptide binding site ([@bib51]; [@bib22], [@bib23]) exhibited large chemical shift perturbations ([Figure 4](#fig4){ref-type="fig"}), further suggesting that both peptides interact with the Dvl PDZ domain. Moreover, during the Dvl-C peptide titration, a few resonances of the PDZ domain disappeared and reappeared ([Figure 4](#fig4){ref-type="fig"}), indicating that the Dvl-C peptide binds to the Dvl1 PDZ domain with higher binding affinity than the Dsh-C peptide does and that the complex is formed in the intermediate exchange range on the NMR time scale.10.7554/eLife.08142.006Figure 4.Direct interaction of the Dvl C-terminus and PDZ domain.(**A**) Overlap of ^1^H-^15^N HSQC spectra of ^15^N-labeled PDZ domain without (blue) and with the unlabeled peptide (SEFFVDVM) derived from the extreme C-terminus of Dvl. Free: blue; final: red; ratio of peptide:protein = 20:1. (**B**) Overlap of ^1^H-^15^N HSQC spectra of ^15^N-labeled PDZ domain without (blue) and with unlabeled peptide (QDVSVSNYVL) derived from the C-terminus of Drosophila Dsh (Dsh-C). Blue: free; red: final; ratio of peptide:protein = 20:1.**DOI:** [http://dx.doi.org/10.7554/eLife.08142.006](10.7554/eLife.08142.006)

To structurally analyze the binding of the Dvl-1 PDZ domain and the Dvl-C peptide, we determined the solution structure of the complex that formed ([Figure 5](#fig5){ref-type="fig"}). The Dvl PDZ domain contains six β-strands (βA∼βF) and two α-helix (αA and αB) structures ([@bib51]; [@bib22], [@bib23]). As expected, we found that the Dvl-C peptide fits into the αB/βB peptide-binding groove of the Dvl PDZ domain and forms an additional β-strand with the αB-structure of the Dvl PDZ domain ([Figure 5A--C](#fig5){ref-type="fig"}). Nuclear Overhauser effect (NOE) data indicated that six residues in the Dvl-C peptide participate in binding ([Figure 5---source data 1, 2](#SD1-data){ref-type="supplementary-material"}). The side chain of Met(0) in the Dvl-C peptide is located within a hydrophobic pocket formed by the side chains of residues Leu262, Ile264, and Ile266 in the βB-structure and residues Val325, Leu321, and Val318 in the αB-helix structure ([Figure 5C,D](#fig5){ref-type="fig"}). Notably, the side chain of residue Asp(-2) in the Dvl-C peptide forms a hydrogen bond with the side chain of residue Arg322 in the Dvl PDZ domain ([Figure 5E](#fig5){ref-type="fig"}). Consistent with this finding, the Arg322Ala substitution dramatically weakened the binding of Dvl PDZ to the Dvl-C peptide ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}) ([@bib22]). The side chains of two hydrophobic Dvl-C residues, Val(-3) and Phe(-5), interact with the side chains of the Val318 and Ile266 residues in the Dvl PDZ domain ([Figure 5E](#fig5){ref-type="fig"}).10.7554/eLife.08142.007Figure 5.Solution NMR structure of Dvl PDZ domain in complex with Dvl-C peptide.(**A**) 2D plane of 3D ^13^C-F1-half-filtered F2-edited NOESY-HSQC spectrum (mixing time, 300 ms) at 15°C. The ratio of peptide:protein was 10:1. \[^13^C,^15^N-PDZ\] = ∼1 mM. (**B**) A stereo view of the backbone of 15 superimposed structures of the Dvl PDZ--Dvl-C peptide complex. (**C**) Ribbon diagram of the lowest-energy structure of the Dvl PDZ/Dvl-C peptide complex. (**D**) Surface of Dvl-1 PDZ bound to Dvl-C peptide (carbon, green; nitrogen, blue; sulfur, yellow; oxygen, red; hydrogen atoms are omitted for clarity). (**E**) Structural details of the Dvl-C peptide--PDZ domain complex. The side chain of Asp(-2) in the Dvl-C peptide forms a hydrogen bond with the side chain of Arg322 on the αB-structure.**DOI:** [http://dx.doi.org/10.7554/eLife.08142.007](10.7554/eLife.08142.007)10.7554/eLife.08142.008Figure 5---source data 1.Intermolecular NOEs between the Dvl-C peptide and the PDZ domain obtained from ^13^C-half-filtered NOESY-HSQC spectra^a^.**DOI:** [http://dx.doi.org/10.7554/eLife.08142.008](10.7554/eLife.08142.008)10.7554/eLife.08142.009Figure 5---source data 2.Structure statistics for the 15 lowest-energy peptide-PDZ complexes.**DOI:** [http://dx.doi.org/10.7554/eLife.08142.009](10.7554/eLife.08142.009)10.7554/eLife.08142.010Figure 5---figure supplement 1.The mutant Dvl-1 PDZ (R322A) domain binds more weakly than wild-type Dvl-1 PDZ domain to the Dvl-C peptide.Overlap of the ^1^H-^15^N HSQC spectra of the labeled mutant Dvl PDZ (R322A) domain and the Dvl-C peptide. The mutation dramatically weakens interaction with the Dvl-C peptide (free: blue; final titration: red; final peptide:protein ratio = 4:1).**DOI:** [http://dx.doi.org/10.7554/eLife.08142.010](10.7554/eLife.08142.010)

The binding pocket of Dvl PDZ is occupied by its intrinsic C-terminus {#s2-3}
---------------------------------------------------------------------

To verify that the binding pocket of the Dvl PDZ domain is occupied by the intrinsic C-terminus, we generated two constructs: mC1 (residues 251--695 of mouse Dvl-1), containing the PDZ and DEP domains (with an intact PDZ-binding motif) and mC1-CΔ7 (residues 251--688), lacking the PDZ-binding motif. We then examined the binding of Rox-DprC to the two constructs. Little polarization change was observed when mC1 proteins were added to Rox-DprC solution, whereas large polarization changes were induced by adding mC1-CΔ7 ([Figure 6](#fig6){ref-type="fig"}), indicating that the binding pocket of the Dvl PDZ domain was occupied by its intrinsic C-terminus in the mC1 construct. The binding affinity between Rox-DprC and mC1-CΔ7 was 3.7 ± 0.5 μM, closely approximating the affinity between Rox-DprC and the Dvl-1 PDZ domain. In contrast, the estimated binding affinity between Rox-DrpC and mD1 was greater than 70 μM, suggesting not only that the Dvl PDZ domain binds intrinsically to the Dvl C-terminus but also that this binding interferes with interactions between the Dvl PDZ domain and its other binding partners in the Wnt signaling pathways.10.7554/eLife.08142.011Figure 6.The binding pocket of the Dvl PDZ domain can be occupied by its intrinsic C-terminus.(**A**) Schematic representation of protein constructs mC1 (residues 251--695) and mC1-CΔ7 (residues 251--688) numbered according to the mouse Dvl-1 protein sequence. (**B**) Polarization change of the fluorescence-labeled peptide Rox-DprC (Rox-SGSLKLMTTV, derived from the C-terminus of Dpr) after addition of mC1-CΔ7 and mC1 proteins in 50 mM phosphate with 0.3 M NaCl and 6 mM β-mercaptoethanol. For the binding of Rox-DprC to mC1, KD is 3.8 ± 0.5 μM the value was obtained by fitting the titration data with the equation: ΔmP = ΔmP~max~ × \[P\]/(\[P\] + K~D~), where ΔmP is the polarization change of Rox-DprC, \[P\] is the concentration of protein, and both K~D~ and ΔmP~max~ are the fitting variables. For the binding of Rox-DprC to mC1-CΔ7, K~D~ was estimated as 68 ± 5 μM. Because of the limitation in the titration study, to estimate the K~D~ value, although we used the same equation to fit the titration data, in the fitting, Kd was the only variable and the maximum polarization change, ΔmP~max~, was fixed to the value that was obtained in the titration study of Rox-DprC binds to mC1-CΔ7.**DOI:** [http://dx.doi.org/10.7554/eLife.08142.011](10.7554/eLife.08142.011)

Dvl conformational change significantly affects Wnt-regulated cell polarity {#s2-4}
---------------------------------------------------------------------------

After establishing that Dvl can adopt a 'closed' conformation in which its C-terminus binds to its PDZ domain, we used a *Xenopus* model (*Xenopus* Dvl-2, XDsh) ([@bib42]; [@bib41]; [@bib47]) to investigate how this intrinsic interaction affects the role(s) of Dvl in the Wnt signaling pathways. We first generated two constructs, both myc-tagged at the N-terminus: wild-type *XDsh* (residues 1--732) ([@bib41]) and mutant *XDsh-CΔ8* (residues 1--724, lacking the C-terminal PDZ-binding motif and therefore unable to form the intrinsic interaction between the its PDZ domain and the C-terminus). To avoid interfering the function of Dvl C-terminus, we placed the myc-tag at the N-terminus. However, the tag may affect the N-terminal DIX domain or potentially have some nonspecific effects. Therefore, in the *Xenopus* studies, we always paired the two constructs in the experiments to minimalize the potential of unexpected effects.

To examine canonical Wnt signaling, we used a luciferase assay with a *siamois* promoter reporter ([@bib6]). The *Xenopus* Wnt target gene construct with *siamois* promoter-driven luciferase reporter and equivalent quantities of *XDsh-CΔ8* and wild-type *XDsh* mRNA, respectively, were coinjected into the animal pole region of 2-cell *Xenopus* embryos, and luciferase activity was then assayed in ectodermal explants dissected at the late blastula stage. Three different doses (80 pg, 200 pg, and 500 pg) of *XDsh* and *XDsh-CΔ8* mRNAs were used. At low and intermediate doses, neither XDsh nor XDsh-CΔ8 substantially affected canonical Wnt signaling (not shown). At the high dose, both constructs enhanced canonical Wnt signaling, but wild-type XDsh was a stronger activator ([Figure 7](#fig7){ref-type="fig"}), consistent with a previous report showing involvement of the extreme C-terminal region of Dvl in activation of canonical Wnt signaling ([@bib44]).10.7554/eLife.08142.012Figure 7.Effect of wild-type XDsh and XDsh-CΔ8 activity on canonical Wnt signaling.Luciferase assay using a *Siamois* promoter reporter (*Sialuc*). *Sialuc* DNA (200 pg) was injected alone or with myc-tagged *Xdsh* or *Xdsh-CΔ8* mRNA (500 pg) into the animal pole region of 2-cell Xenopus embryos. Ectodermal explants were dissected at the early gastrula stage for luciferase assay. Values are the means ±SD from four independent experiments (p \< 0.05). Inset shows a representative western blot using anti-myc antibody (9E10) to control for XDsh and XDsh-CΔ8 protein expression in the four experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.08142.012](10.7554/eLife.08142.012)

To examine how the conformational change of Dvl affects the Wnt-regulated CE phenotype (associated with the non-canonical Wnt signaling), we injected three different doses of wild-type *XDsh* and of *XDsh-CΔ8* mRNA into the dorsal blastomeres of 4-cell *Xenopus* embryos. At all three doses (80 pg, 200 pg, and 500 pg), *XDsh-CΔ8* mRNA caused greater body axis shortening and dorsal tail flexion than did wild-type *XDsh* ([Figure 8A](#fig8){ref-type="fig"}), suggesting that XDsh-CΔ8 is more active than wild-type XDsh in inducing the CE phenotype. We then compared Xdsh-CΔ8 with another Dvl mutant that lacks the PDZ domain, the well-established Xdd1 ([@bib41]). Like XDsh-CΔ8, Xdd1 is in 'open' conformation because it has no PDZ domain to interact with its C-terminus. We injected equal quantities (500 pg) of N-terminal myc-tagged *Xdd1*, *XDsh-CΔ8*, and wild-type *XDsh* mRNA, respectively, into the dorsal blastomeres of 4-cell *Xenopus* embryos and found that the phenotypes were very similar after injection of *XDsh-CΔ8* and after injection of *Xdd1* ([Figure 8B](#fig8){ref-type="fig"}), suggesting that the 'open' Dvl is more active than the 'closed' wild-type Dvl in inducing the *Xenopus* CE phenotype.10.7554/eLife.08142.013Figure 8.The open conformation of Dvl significantly enhances gain-of-function planar cell polarity (PCP) signaling.(**A**) Xenopus embryonic abnormal convergent extension (CE) phenotypes induced by injection of wild-type *XDsh* and *XDsh-CΔ8* mRNA at three increasing concentrations (arrows at bottom represent 80 pg, 200 pg and 500 pg of injected mRNA; above are numbers of embryos injected from two independent experiments). Phenotypes are severe (green), mild (red), and normal (blue). (**B**) Comparison of phenotypes induced by dose-equivalent injections (500 pg mRNA) of *XDsh*, *XDsh-CΔ8*, and *Xdd1* (a well-established dominant-negative *XDsh* mutant). XDsh-CΔ8 and Xdd1 induced similar phenotypes. The numbers of embryos injected from three independent experiments are listed on the top of each column.**DOI:** [http://dx.doi.org/10.7554/eLife.08142.013](10.7554/eLife.08142.013)

The open conformation of Dvl activates JNK more effectively {#s2-5}
-----------------------------------------------------------

In *Xenopus* embryos, JNK is known to regulate CE through non-canonical Wnt-PCP signaling ([@bib41], [@bib40]; [@bib19]), and either hyperactivation or JNK depletion dysregulates CE ([@bib52]). We therefore investigated how the change of Dvl conformation affects JNK activity. We overexpressed wild-type XDsh, Xdd1, and XDsh-CΔ8 in the ventral regions of 4-cell *Xenopus* embryos and dissected the ventral regions at the early gastrula stage to examine JNK phosphorylation by western blot. Overexpression of wild-type XDsh induced slightly greater JNK phosphorylation than observed in uninjected control cells. However, both Xdd1 and XDsh-CΔ8 induced JNK phosphorylation more potently ([Figure 9A](#fig9){ref-type="fig"}), suggesting that deletion of the XDsh C-terminal region renders XDsh more active in the non-canonical Wnt pathway. This finding is consistent with an early report of more effective JNK activation in COS-7 cells expressing mutant Dvl lacking the PDZ domain than in cells expressing wild-type Dvl ([@bib42]; [@bib2]; [@bib25]; [@bib29]; [@bib52]; [@bib13]).10.7554/eLife.08142.014Figure 9.The open conformation of Dvl disrupts CE by activating Jun N-terminal kinase (JNK).(**A**) Western blot of phosphorylated JNK in ventral mesoderm cells overexpressing wild-type XDsh or its mutants. At equivalent protein level, Xdd1 and XDsh-CΔ8 more potently induce JNK phosphorylation than wild-type XDsh. (**B**) Xenopus 4-cell stage embryos were dorsally coinjected with equal quantities of wild-type *XDsh* mRNA or *XDsh-CΔ8* mRNA (500 pg) and the AP1-luciferase reporter DNA (200 pg); luciferase activity was assayed at the late gastrula stage. Inset shows a representative Western blot using anti-myc antibody to control XDsh and XDsh-CΔ8 protein levels. Values are the mean and SD from three independent experiments (XDsh vs XDsh-CΔ8, p \< 0.05). (**C**--**H**) The dominant negative JNK mutant (dnJNK) rescues activin-induced explant elongation blocked by overexpression of XDsh-CΔ8 or Xdd1. (**C**) Uninjected explants treated with activin show extensive elongation. (**D**) *XDsh*-injected explants treated with activin show moderate inhibition of explant elongation. (**E**) Injection of *XDsh-CΔ8* strongly inhibits explant elongation. (**F**) Injection of *Xdd1* similarly inhibits explant elongation as injection of *XDsh-CΔ8*. (**G**, **H**) dnJNK rescues explant elongation inhibited by XDsh-CΔ8 or Xdd1. (**I**) dnJNK also recues CE defects produced by overexpression of XDsh-CΔ8 or Xdd1 in whole embryos. Phenotypes are severe (green), mild (red), and normal (blue). Numbers on the top indicate total embryos scored from three independent experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.08142.014](10.7554/eLife.08142.014)

To further demonstrate that the conformation of Dvl regulates its activation of JNK, we used the AP1-luciferase reporter ([@bib33]) to monitor JNK activation in whole *Xenopus* embryos. When equal quantities (500 pg) of *XDsh-CΔ8* or wild-type *XDsh* mRNA were injected into the dorsal region of 4-cell *Xenopus* embryos and luciferase activity was assayed at the late gastrula stage, XDsh-CΔ8 clearly activated AP1-luciferase activity more strongly ([Figure 9B](#fig9){ref-type="fig"}), indicating that Dvl in the open conformation activates JNK more potently than Dvl in the closed conformation.

To clarify the role of the Dvl C-terminus in JNK activation, we analyzed activin-induced changes in the length and shape of *Xenopus* ectodermal explants; these changes represent the CE phenotype associated with non-canonical Wnt signaling ([Figure 9C--H](#fig9){ref-type="fig"}). In *Xenopus*, both activation and inhibition of non-canonical Wnt signaling result in planar cell polarity (PCP) defects and produce CE phenotype ([@bib10]). Ectodermal explants from control embryos and embryos injected with different mRNAs that encode Dvl and different mutants were dissected at the early blastula stage and treated with activin. The phenotypes were monitored at equivalent early neurula stages. As expected, *XDsh-CΔ8* and the dominant-negative mutant *Xdd1* strongly inhibited the activin-induced elongation of ectodermal explants (CE outcomes) as compared to controls, while wild-type *XDsh* had little effect ([Figure 9D--F](#fig9){ref-type="fig"}). However, co-expression of a dominant-negative JNK mutant (dnJNK), which inhibits non-canonical Wnt signaling ([@bib52]; [@bib7]), with *XDsh-CΔ8* or *Xdd1* efficiently rescued explant elongation ([Figure 9G,H](#fig9){ref-type="fig"}), indicating that the CE defects induced by XDsh-CΔ8 and Xdd1 are the result of JNK activation. In addition, we also confirmed that co-expression of dnJNK with XDsh could also rescue explant elongation (not shown).

Finally, to further confirm that the effect of Dvl\'s open conformation on the CE phenotype resulted from JNK activation, we coinjected *dnJNK* with *XDsh-CΔ8* or *Xdd1*, and analyzed the phenotypes in *Xenopus* whole embryo. Injection of *XDsh-CΔ8* or *Xdd1* alone resulted in embryos with short and bent axis, reflecting CE defects. However, the abnormal CE phenotype was substantially rescued when the embryos were coinjected with *dnJNK* ([Figure 9I](#fig9){ref-type="fig"}), suggesting that JNK activation induced by the Dvl open conformation (i.e., use of XDsh-CΔ8 or Xdd1) had resulted in the CE phenotype.

Obstruction of the Dvl PDZ domain activates JNK {#s2-6}
-----------------------------------------------

Many Wnt signaling regulators directly bind to and inhibit the Dvl PDZ domain ([@bib50]; [@bib48]). To block Wnt signaling transduction at the Dvl level, we also developed a series of small-molecule inhibitors that disrupt Fz--Dvl interaction ([@bib35], [@bib36]; [@bib15]; [@bib37]; [@bib23]). Because all of the Wnt-regulating proteins and small molecule inhibitors target the site on the surface of the Dvl PDZ domain that binds to the molecule\'s own C-terminus, these agents should release the Dvl C-terminus from its intramolecular binding and open the closed conformation of Dvl. These molecules can be used to probe the effect of the conformational change of Dvl. For this study we chose a small molecule inhibitor of Fz--Dvl interaction, compound 3289--8625 ([@bib15]) and a protein inhibitor of Wnt signaling, TMEM88 ([@bib21]).

We previously showed that the small molecule 3289--8625 penetrates the *Xenopus* embryo and binds to the PDZ domain of Dvl ([@bib15]). Microinjection of embryos with *XDsh* mRNA and incubation in medium containing compound 3289--8625 increased the prevalence of the non-canonical Wnt signaling--associated CE phenotype ([Figure 10A](#fig10){ref-type="fig"}). We also previously reported the protein TMEM88 to be a novel Wnt signaling inhibitor whose C-terminal region binds to the Dvl PDZ domain ([@bib21]). When we coinjected embryos with mRNAs encoding the C-terminal half of TMEM88 (TMEM88-C) and wild-type XDsh, abnormal CE phenotypes were again more prevalent than in embryos injected only with *XDsh* mRNA ([Figure 10A](#fig10){ref-type="fig"}); this result is consistent with the fact that gain-of-function of PCP signaling induced by activated Dvl affects gastrulation movements and disrupts axis elongation ([@bib10]). CE defects were much less prevalent in control embryos incubated in 3289--8625 or injected with TMEM88-C mRNA alone ([Figure 10A](#fig10){ref-type="fig"}).10.7554/eLife.08142.015Figure 10.The open conformation of Dvl induced by targeting the Dvl PDZ domain potentiates Wnt/JNK signaling.(**A**) Regulation of XDsh-mediated PCP signaling by a PDZ-binding small molecule or peptide is shown by the gain-of-function CE phenotypes of whole embryos that were uninjected (controls) or injected with *XDsh* mRNA with or without treatment with the Dvl inhibitors 3209--8625 or coinjected with *XDsh* and *TMEM88-C* mRNAs. (**B**) Inhibiting the Dvl PDZ domain blocks canonical Wnt signalling induced by Dvl overexpression. Wild-type *XDsh* mRNA was injected alone or coinjected with an equal quantity of *TMEM88-C* mRNA in the animal pole region of two-cell stage Xenopus embryos, and ectodermal explants were dissected at the late blastula stage. TOPFLASH luciferase activity values are the mean and SD from three independent experiments (p \< 0.05). (**C**) Inhibition of the Dvl PDZ domain by TMEM88 opens the conformation of Dvl and potentiates Wnt/JNK signaling induced by Dvl overexpression. Xenopus 4-cell stage embryos were injected dorsally with wild-type *XDsh* mRNA or coinjected with equal quantities of wild-type *XDsh* mRNA and *TMEM88-C* mRNA. AP1 luciferase activity was assayed at the late gastrula stage. Values are the mean and SD from three independent experiments (p \< 0.05).**DOI:** [http://dx.doi.org/10.7554/eLife.08142.015](10.7554/eLife.08142.015)

To further dissect how inhibition of the Dvl PDZ domain affects Dvl\'s role in the Wnt/β-catenin and Wnt/JNK signaling pathways, we used the TOPFLASH and AP1-luciferase reporter assays. To target the Dvl PDZ domain with TMEM88-C, we again coinjected the embryos with mRNAs encoding TMEM88-C and wild-type XDsh. As we reported previously ([@bib21]), binding of the PDZ domain by TMEM88-C antagonized Wnt/β-catenin activity induced by Dvl overexpression ([Figure 10B](#fig10){ref-type="fig"}). Further, this opening of the Dvl conformation potentiated Wnt/JNK signaling induced by Dvl overexpression ([Figure 10C](#fig10){ref-type="fig"}).

Discussion {#s3}
==========

Here we showed that a C-terminal motif of Dvl can bind intrinsically to the Dvl PDZ domain, forming a 'closed' conformation. Although the binding affinity of this reaction is not notably high, the closed conformation is stable and may predominate among intracellular Dvl proteins ([@bib53]). To compare the effects of the two Dvl conformations, we examined a C-terminal--truncated Dvl mutant, the established Xdd1 mutant (neither of these forms the 'closed' conformation in solution), and wild-type Dvl in different *Xenopus* assays and found that both of the 'open' Dvl constructs significantly enhanced the CE phenotype mediated by Wnt-JNK signaling. To further support this observation we observed the competitive binding to the PDZ domain of the Dvl C-terminus and two agents known to bind the Dvl PDZ domain―the peptide TMEM88-C and the small-molecule inhibitor 3289--8625 ([@bib15]); we reasoned that by competing with the intrinsic binding of the C-terminus, these two agents should induce an open Dvl conformation. Indeed, the two molecules enhanced JNK activation by wild-type Dvl. Interestingly, consistent with these findings, several groups have reported that JNK is activated by sulindac, a nonsteroidal anti-inflammatory drug we previously demonstrated to bind to the Dvl PDZ domain ([@bib9]; [@bib32]; [@bib23]; [@bib39]). Therefore, we conclude that the open conformation of Dvl is likely to initiate JNK activation.

Dvl has been suggested to exist in activated and inactivated states within the cell and to be activated by Wnt signals ([@bib20]; [@bib50]; [@bib48]; [@bib14]); however, the form of the 'active state' has not been determined. Our findings suggest that the activation state of Dvl is determined by its conformation, such that in the absence of Wnt ligand, Dvl adopts a closed conformation that represents its inactive state. Wnt signaling opens the closed conformation of Dvl and thereby activates Dvl. For example, in a working model of the canonical Wnt signaling pathway, the simultaneous binding of Wnt ligand to both of its membrane-bound receptors, Fz and LRP5/6, initiates canonical Wnt signaling by causing dimerization of the two receptors. Within the cell, the close proximity of the two receptors\' cytoplasmic tails triggers the formation of signalosomes ([@bib3]) containing Dvl and Axin; Dvl binds to Fz through its PDZ domain ([@bib51]), thus acquiring the open conformation. This open conformation also allows the Dvl DEP domain to interact with the membrane through nonspecific charge--charge interactions ([@bib30]; [@bib45]; [@bib2]; [@bib51]; [@bib31]; [@bib49]; [@bib34]; [@bib38]) that in turn promote the Fz--Dvl interaction. Axin binds LRP5/6 ([@bib28]; [@bib43]), and the DIX domains of Dvl and Axin interact to further stabilize the complex ([@bib34]; [@bib12]). The network of interactions in the super-complexes stabilizes the signalosomes remarkably, although the individual interactions are relatively weak. Energetically, the super-complex is more stable than the closed conformation of Dvl and therefore can capture the PDZ domain of Dvl. By ousting the Dvl C-terminus from its bond with the Dvl PDZ domain, the Fz binding motif also opens the conformation of Dvl as it is captured in the signalosome. Although other Wnt signaling pathways are less well defined, it is clear that most, if not all, non-canonical Wnt pathways are triggered by the interaction between Fz and Dvl, which is likely to open the conformation of Dvl as well ([@bib16]; [@bib14]). Therefore, we propose that the active form of Dvl is its open conformation and that this active form initiates JNK-related Wnt signaling pathways.

The Dvl DEP domain is essential to activate JNK cascades ([@bib5]). The hypothesis that 'opened' Dvl stimulates JNK activity is consistent with a report that Daam1, a key player that connects Dvl to JNK, exists in an autoinhibited state and is activated by binding to Dvl ([@bib26]). Daam1 binds to the Dvl DEP domain ([@bib17]), which is likely to be obstructed in the closed conformation. Therefore, opening of Dvl\'s conformation is a key step in the Wnt-stimulated cascade that activates JNK.

Materials and methods {#s4}
=====================

Protein expression and purification {#s4-1}
-----------------------------------

The cDNAs encoding the PDZ (residues 251--340), DEP (residues 377--503), mC1 (residues 251--695), and mD1-CΔ7 (residues 251--688) domains of mouse Dvl-1 were sub-cloned into the pET28a vector. The N-terminally 6xHis-tagged proteins were expressed in BL21(DE3) *Escherichia coli* and purified by Ni-affinity chromatography followed by gel filtration chromatography as we described previously ([@bib51]) and describe in the supplementary information.

Peptide synthesis and purification {#s4-2}
----------------------------------

Peptides were synthesized by the Hartwell Center for Bioinformatics & Biotechnology at St. Jude Children\'s Research Hospital; they were purified by reverse-phase high-performance liquid chromatography and confirmed by MSI-MS as described in the supplementary information.

Binding studies {#s4-3}
---------------

For the fluorescence spectroscopy studies, a Fluorolog-3 spectrofluorometer (HORUBA Instruments Inc, Edison, NJ) with a 10 × 4 mm quartz cell (Hellma Inc.) with magnetic stirring was used. To confirm that the binding site of the Dvl-1 PDZ domain was occupied by intrinsic C-terminus, we generated two proteins, mC1 and mC1-CΔ7, which were separately titrated into the fluorescence-labeled peptide Rox-DprC. The K~I~ of both peptides was determined in two independent experiments by using the equation K~D~^app^ = K~D~ (1 + \[I\]/K~I~), where K~D~^app^ is the apparent K~D~ of Rox-Dpr-C with the Dvl-C or Dsh-C peptide and \[I\] is the concentration of both peptides ([Figure 2](#fig2){ref-type="fig"}). For the ITC studies, Auto-iTC-200 (MicroCal) was used to obtain the binding affinity of Dvl-C peptide and Dvl PDZ protein in 50 mM phosphate buffer. The concentration of Dvl-C peptide in the syringe was 1.05 mM and the concentration of Dvl PDZ domain in the cell was 0.114 mM ([Figure 3](#fig3){ref-type="fig"}). The K~D~ value was averaged from two independent experiments at 25°C.

NMR spectroscopy {#s4-4}
----------------

All NMR experiments were performed at 15°C using Bruker Avance 800-MHz spectrometers equipped with triple-resonance, 5-mm triple axis--shielded gradient probes. For titration experiments we used the Varian Unity INOVA 600 MHz spectrometer equipped with a triple-resonance, 5-mm triple-axis shielded gradient probe at 25°C.

Structure determination of the Dvl-1 PDZ/Dvl-C peptide complex {#s4-5}
--------------------------------------------------------------

We used NMR-derived data and a simulated annealing protocol using the program CNS within the HADDOCK software (ver. 1.2) ([@bib11]). Coordinates of mouse Dvl PDZ were taken from the X-ray structure of the *Xenopus* PDZ domain (1L6O:A), whose amino acid residues were modified to fit the mouse Dvl PDZ domain ([@bib51]). Two different types of restraints were used to determine the complex structures: (1) Ambiguous interaction restraints were chosen on the basis of the chemical shift perturbation, intermolecular NOEs between the Dvl-C peptide/PDZ complex, and solvent accessibility (calculated by using the program NACCESS \[[@bib18]\]); (2) Unambiguous distant restraints were obtained from several different types of NOESY experiments, including 2D \[F1,F2\]-double filtered NOESY experiments and 3D F1-half-filtered and F2-edited ^13^C-NOESY-HSQC experiments using the ^13^C/^15^N PDZ domain of Dvl with unlabeled Dvl-C peptide. NOE restraints were grouped into distance ranges according to their relative intensity: strong (1.8--2.5 and 1.8--3.0 Å), medium (1.8--4.0 Å), and weak (1.8--5.0 Å). A total of 45 unambiguous restraints (23 sequential intramolecular NOEs from the Dvl-C peptide bound to the PDZ domain and 22 intermolecular NOEs between the Dvl-C peptide and the Dvl-1 PDZ domain) were used. Two types of restraints were combined to generate 2000 initial structures of the Dvl PDZ/Dvl-C peptide complex; 200 of these structures were selected by using NOE-derived restraints, and 100 structures were then obtained for final refinement. We ultimately selected the 15 lowest-energy conformers from the final 100 complex structures for further structural analysis.

*Xenopus* embryos and microinjection of mRNA {#s4-6}
--------------------------------------------

*Xenopus* eggs were obtained from females previously injected with 500 IU of human chorionic gonadotropin (Sigma) and artificially fertilized. Synthesis, microinjection of capped mRNAs, and treatment of ectodermal explants with activin were previously described ([@bib7]). After microinjection, some embryos were incubated in medium containing 2 μg/ml of the small-molecule compound 3289--8625 until the desired stage ([@bib15]).

Luciferase-based assays {#s4-7}
-----------------------

To examine canonical Wnt signaling, both the *siamois* promoter--driven luciferase reporter ([@bib6]) and the TOPFLASH luciferase reporter were used. The *siamois* promoter reporter DNA construct (*Sialuc*, 200 pg) or the TOPFLASH reporter DNA construct (200 pg) was injected, alone or with mRNA (500 pg) encoding wild-type XDsh or a mutant XDsh-CΔ8 lacking the PDZ-binding motif, into the animal pole region of 2-cell *Xenopus* embryos. Ectodermal explants were dissected from injected embryos at the late blastula stage. To assess non-canonical Wnt signaling, we used the AP1-luciferase reporter ([@bib33]) to monitor activation of JNK in *Xenopus* whole embryos. The reporter DNA (200 pg) was injected alone or coinjected with equal quantities (500 pg) of *XDsh-CΔ8* or wild-type *XDsh* mRNA into the dorsal region of 4-cell *Xenopus* embryos, which were allowed to develop to late gastrula stage. A Lumat LB9507 luminometer (Berthold Technologies GmbH & Co) was used to perform the luciferase assays (Promega). We used cell lysates from 10 explants or five whole embryos to measure luciferase activity. All experiments were performed at least in triplicate using different batches of embryos and the mean value was calculated using Student\'s *t*-test.

Western blot assays {#s4-8}
-------------------

Synthetic mRNAs (500 pg) corresponding to myc-tagged wild-type XDsh and different mutants were injected into the ventral blastomeres of *Xenopus* embryos at the 4-cell stage. At the early gastrula stage, 10 ventral mesoderm explants were dissected and analyzed by western blot using anti-phospho-JNK (Thr183/Tyr185, Thr221/Tyr223) antibody (Millipore) and anti-myc 9E10 antibody (Santa-Cruz Biotechnology).

*Xenopus* whole embryo and ectodermal explant studies {#s4-9}
-----------------------------------------------------

The two dorsal blastomeres of 4-cell *Xenopus* embryos were injected with mRNA (500 pg) encoding XDsh, XDsh-CΔ8, or Xdd1, either alone or with mRNA (500 pg) encoding dnJNK. For the dose-depending studies, three different amounts of *XDsh* and *XDsh-CΔ8* mRNAs (80 pg, 200 pg and 500 pg) were used. The embryos were cultured to the larval stage, then grouped and counted according to normal, mild, or severe CE abnormal (JNK gain-of-function) phenotype. To investigate the effect of XDsh, XDsh-CΔ8, and Xdd1 on CE in vitro, the same mRNAs were injected, alone or with *dnJNK* mRNA, into the animal pole region of 2-cell *Xenopus* embryos. Ectodermal explants were dissected at the early blastula stage, incubated with activin for 1 hr, cultured to the early neurula-stage equivalent, and examined for the extent of explant elongation. To investigate how the C-terminal region of TMEM88 affects Dvl function, equal amounts of mRNAs (500 pg) encoding the C-terminal half of TMEM88 (TMEM88-C) and wild-type XDsh were coinjected into the two dorsal blastomeres at the 4-cell stage, and the embryos were again grouped and counted as having normal, mild, or severe CE phenotypes. The above experiments were performed at least twice using different batches of embryos.
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Thank you for submitting your work entitled "Conformational change of Dishevelled plays a key regulatory role in the Wnt signaling pathways" for peer review at *eLife*. Your submission has been favorably evaluated by John Kuriyan (Senior editor), a Reviewing editor, and three reviewers, one of whom, Sergei Sokol, has agreed to share his identity.

The reviewers have discussed the reviews with one another and the Reviewing editor has drafted this decision to help you prepare a revised submission. The three full reviews (lightly edited) are included in this letter, as there are some specific and useful suggestions in them that will not be repeated in the summary here.

All of the reviewers were impressed with the importance and novelty of your work. We look forward to receiving the revised version of your manuscript.

Reviewer \#1:

Lee et al. present evidence that the Dvl PDZ domain binds to the Dvl C-terminus, and that disrupting this interaction leads to activation of Wnt/JNK signaling. Since Dvl critical for both Wnt /β-catenin and PCP signaling, this is a very intriguing set of findings. The work seems technically solid. There are a few points that the authors should address, however.

1\) The intramolecular interaction of the PDZ and C-terminus is described as a "closed conformation". Do the authors see differences in hydrodynamic radius of the purified proteins (e.g. SEC, DLS) when the interaction is disrupted?

2\) The data in [Figure 7](#fig7){ref-type="fig"} are used to argue that the Dvl C-terminus has an important role in Wnt/β-catenin signaling, since deletion of this region doesn\'t produce a strong activation of luciferase activity. Yet high doses the full-length protein gives the well-known effect. Is this because some fraction of the overexpressed full-length protein is "open"? Also, what does deletion of the PDZ domain do in this assay?

3\) Since deletion of either the PDZ or the C-terminus produces similar phenotypes, neither is implicated in directly activating JNK signaling. It is not clear from the Discussion how the authors think the activation may be occurring. Also, do the authors have an idea about a potential role of the PDZ-Fzd interaction?

4\) I originally thought that the "closed conformation" is the one used for beta-catenin activation, but this is not what the authors are claiming -- they think ablating the PDZ-C-term interaction is important for both, although they muddle through this point in the penultimate paragraph. I think we agree that they need to clarify their discussion on beta-catenin signaling. I also agree that they need to discuss the earlier papers on Dvl/JNK signaling more carefully.

5\) Re [Figure 2B](#fig2){ref-type="fig"}, this also confused me until I realized that the protein alone lanes have no beads -- these are just input protein markers. But, they don\'t do the control of beads alone nor (better) a scrambled peptide. In any case this needs to be corrected.

Reviewer \#2:

This work relates to the mechanism of Dishevelled activation by the Wnt pathway. The authors provide significant evidence uncovering a physical interaction between the PDZ domain of the protein and the C-terminal PDZ-binding motif. Since the two domains might be expected to interact, this result, on its own, is not a surprise, but the authors propose that this interaction is critical for the ability of Dishevelled to signal. According to their model, the intramolecular association is responsible for the closed conformation of Dishevelled, which prevents JNK activation and convergent extension defects (referred to as noncanonical signaling). The comparison of Dishevelled constructs shows that the protein with a deleted C-terminus (C∆8) and the one with a nonfunctional PDZ domain (Xdd1) activate JNK and interfere with convergent extension stronger than the wild-type protein. Similar effects are observed for two Dvl antagonists that bind to the PDZ domain, consistent with the proposed model. Interestingly, the effects on beta-catenin reporters are opposite to those obtained for AP-1 luciferase, suggesting that the 'open conformation' of Dishevelled inhibits canonical Wnt signaling. This is another important point, although it is not emphasized in the manuscript.

This study is interesting because of the critical role of Dishevelled in Wnt signaling, the experiments are overall solid, with some typos and controls missing. To verify their conclusions obtained for the C-terminally truncated construct (C∆8), the authors are recommended to make specific point mutations disrupting the PDZ binding motif and, possibly, the PDZ domain. They should also confirm that the inhibitors used (TMEM88-C and 8625) interfere with the PDZ-PBD binding in vitro. I feel that the paper would benefit from showing an effect of a Wnt signal on the proposed intramolecular interaction, although these experiments might be considered beyond the scope of the present study. The authors should discuss early papers on Dishevelled and JNK signaling, such as [@bib5] in Cell, which are not fully consistent with the proposed model.

Reviewer \#3:

The authors address the potential role of intramolecular interactions between the Dsh/Dvl C-terminal sequences and its PDZ domain. They establish through a series of biochemical/structural techniques and a follow up biology in *Xenopus* that Dsh/Dvl is normally in a closed confirmation (with the C-term residues bound to the PDZ domain) and open Wnt-signaling activation it is "opened" up with the C-term residues being released from the PDZ and allowing the full length protein to bind to and activate downstream effectors, like for example JNK signaling in the Wnt/PCP signaling context or interaction with Axin in the canonical signaling pathway.

The observations presented here are of significance and relevance and worth publishing in *eLife*. I have however a few concerns that should be addressed prior to publication.

1\) Based on the presented data, both the canonical and the PCP (non-canonical) Wnt pathway are more "effective" in the open configuration. Yet, in the Abstract the authors state: "Wnt-regulated CE is more readily affected by Dvl mutants unable to form the closed conformation than wild-type Dvl\...non-canonical signaling is mediated by the open conformation of Dvl\...". I assume the authors refer to CE and non-canonical signaling as the same (PCP-type Wnt signaling) and yet they state that one is "more affected". This part of the Abstract is very unclear and needs to be rewritten.

2\) The authors state (in the subsection "The binding pocket of Dvl PDZ is occupied by its intrinsic ligand"): "\... suggesting not only that the Dvl PDZ domain binds intrinsically to the Dvl C-terminus but also that this binding interferes with interactions between the Dvl PDZ domain and its other binding partners in the Wnt signaling pathways". How does this work with the presumed Fz C-tail Dvl PDZ interaction, which has been shown to be essential for Fz induced Dsh/Dvl membrane recruitment and thus activation; this was published by the same authors \[Wong et al., Mol Cell 2003\].

3\) Throughout the paper the biochemical and biological experiment quantifications lack statistical analyses, e.g. [Figures 7, 8, 9 and 10](#fig7 fig8 fig9 fig10){ref-type="fig"}.

4\) The data presented in [Figure 9I](#fig9){ref-type="fig"} lacks several controls. The authors need to include "uninjected" and "xDsh alone".

5\) Some biological assays in a real in vivo/genetic setting (mouse or *Drosophila*) would have been helpful. The *Xenopus* experiments suffer from massive overexpression and pure gain-of-function approaches. Does the model hold up in a loss-of-function genetic context?

10.7554/eLife.08142.017

Author response

Reviewer \#1:

*Lee et al. present evidence that the Dvl PDZ domain binds to the Dvl C-terminus, and that disrupting this interaction leads to activation of Wnt/JNK signaling. Since Dvl critical for both Wnt /β-catenin and PCP signaling, this is a very intriguing set of findings. The work seems technically solid. There are a few points that the authors should address, however*.

1\) The intramolecular interaction of the PDZ and C-terminus is described as a "closed conformation". Do the authors see differences in hydrodynamic radius of the purified proteins (e.g. SEC, DLS) when the interaction is disrupted?

We did not see definitive difference between "closed" and "open" forms of Dvl in the SEC studies. Our DLS studies were also unsuccessful partially because it was very difficult to concentrate the proteins. However, we did obtain a set of data from an analytical ultracentrifugation study (shown in [Author response image 1](#fig11){ref-type="fig"}). The shapes of the data fit perfectly well with our model; the data shows that the "closed" form (C1) is more globular than the "open" form (C1-Δ7) ([Author response image 1](#fig11){ref-type="fig"}). However, the numbers extracted from data, such as hydrodynamic radius (Rstocks), for the two forms of Dvl are essentially the same. We speculated that this might be due to the large flexible loop in the "closed" form. Because of this inconsistence, we decided not to include the ultracentrifugation data in the manuscript.10.7554/eLife.08142.018Author response image 1.**DOI:** [http://dx.doi.org/10.7554/eLife.08142.018](10.7554/eLife.08142.018)

*2) The data in* [*Figure 7*](#fig7){ref-type="fig"} *are used to argue that the Dvl C-terminus has an important role in Wnt/β-catenin signaling, since deletion of this region doesn\'t produce a strong activation of luciferase activity. Yet high doses the full-length protein gives the well-known effect. Is this because some fraction of the overexpressed full-length protein is "open"? Also, what does deletion of the PDZ domain do in this assay?*

Indeed, some fraction of the full-length Dvl is in "open" form. This issue is discussed and showed in [Figure 6](#fig6){ref-type="fig"} in the manuscript.

Because the Fzd-PDZ interaction plays a key role in Wnt/β‐catenin signaling, therefore, deletion of the PDZ domain will block the signaling. In fact, it was showed that deletion of the PDZ domain abolishes the activity of Dsh in canonical Wnt signaling ([@bib41], Curr Biol 6:1456‐1467). However, it is a different issue from what we aim to address in the current manuscript.

3\) Since deletion of either the PDZ or the C-terminus produces similar phenotypes, neither is implicated in directly activating JNK signaling. It is not clear from the Discussion how the authors think the activation may be occurring. Also, do the authors have an idea about a potential role of the PDZ-Fzd interaction?

As we discussed in the Discussion section, we clearly state that although we propose a few possibilities, we don't know exactly how JNK is activated through Dvl. What we report in the manuscript is our observations that the "open" conformation of Dvl was more effective in triggering JNK activation.

Regarding the potential role of the PDZ-Fzd interaction, as we discuss in the Discussion section, this interaction should open the "closed" Dvl to the "open" form.

*4) I originally thought that the "closed conformation" is the one used for beta-catenin activation, but this is not what the authors are claiming -- they think ablating the PDZ-C-term interaction is important for both, although they muddle through this point in the penultimate paragraph. I think we agree that they need to clarify their discussion on beta-catenin signaling. I also agree that they need to discuss the earlier papers on Dvl/JNK signaling more carefully*.

Actually, at this moment, based on all the data we have, we believe that the "open" conformation of Dvl is more active in all the Dvl mediated Wnt signaling pathways. This issue is discussed in the Discussion section.

*5) Re* [*Figure 2B*](#fig2){ref-type="fig"}*, this also confused me until I realized that the protein alone lanes have no beads -- these are just input protein markers. But, they don\'t do the control of beads alone nor (better) a scrambled peptide. In any case this needs to be corrected*.

This point is well taken; we removed the figure in the revised manuscript.

Reviewer \#2:

*\[...\] This study is interesting because of the critical role of Dishevelled in Wnt signaling, the experiments are overall solid, with some typos and controls missing. To verify their conclusions obtained for the C-terminally truncated construct (C∆8), the authors are recommended to make specific point mutations disrupting the PDZ binding motif and, possibly, the PDZ domain*.

Because the nature of PDZ domain, it is very difficult to identify such a mutant that has significant reduction in binding affinity to its binding partners yet maintain the integrity of the protein.

*They should also confirm that the inhibitors used (TMEM88-C and 8625) interfere with the PDZ-PBD binding in vitro*.

We did the experiment according to the reviewer's suggestion and the data are incorporated in the new [Figure 10](#fig10){ref-type="fig"}.

*I feel that the paper would benefit from showing an effect of a Wnt signal on the proposed intramolecular interaction, although these experiments might be considered beyond the scope of the present study*.

We discuss this issue in the Discussion section.

*The authors should discuss early papers on Dishevelled and JNK signaling, such as* [@bib5] *in Cell, which are not fully consistent with the proposed model*.

The reference was mistakenly omitted during the editing of the original manuscript. We sincerely apologize for this mistake. The reference is added back.

We think our proposed model is actually consistent with the Cell paper. This issue is discussed in the Discussion section.

Reviewer \#3:

*\[...\] The observations presented here are of significance and relevance and worth publishing in* eLife*. I have however a few concerns that should be addressed prior to publication*.

*1) Based on the presented data, both the canonical and the PCP (non-canonical) Wnt pathway are more "effective" in the open configuration. Yet, in the Abstract the authors state: "Wnt-regulated CE is more readily affected by Dvl mutants unable to form the closed conformation than wild-type Dvl\...non-canonical signaling is mediated by the open conformation of Dvl\...". I assume the authors refer to CE and non-canonical signaling as the same (PCP-type Wnt signaling) and yet they state that one is "more affected". This part of the Abstract is very unclear and needs to be rewritten*.

We reword the sentence in the Abstract according to the suggestion of the reviewer.

*2) The authors state (in the subsection "The binding pocket of Dvl PDZ is occupied by its intrinsic ligand"): "\... suggesting not only that the Dvl PDZ domain binds intrinsically to the Dvl C-terminus but also that this binding interferes with interactions between the Dvl PDZ domain and its other binding partners in the Wnt signaling pathways". How does this work with the presumed Fz C-tail Dvl PDZ interaction, which has been shown to be essential for Fz induced Dsh/Dvl membrane recruitment and thus activation; this was published by the same authors \[Wong et al., Mol Cell 2003\]*.

Indeed, the Dvl PDZ domain can bind to Dvl C-terminus, Fz C-terminal tail, and many other binding partners. We propose that inside the cell, these interactions compete with each other, and the surrounding condition the Dvl inside the cell determines the binding partner(s) of the Dvl PDZ domain. We discussed this issue in the Discussion section. For example, in the current working model of the canonical Wnt signaling, the binding of Wnt to both its receptors, Fz and LRP5/6 triggers the formation of the signalosome. The network of interactions in the signalosome super-complexes stabilizes the signalosomes remarkably, although the individual interactions are relatively weak. Energetically, the supercomplex is more stable than the "closed" conformation of Dvl and therefore can capture the PDZ domain of Dvl. By ousting the Dvl C-terminus from its bond with the Dvl PDZ domain, the Fz binding motif also opens the conformation of Dvl as it is captured in the signalosome.

*3) Throughout the paper the biochemical and biological experiment quantifications lack statistical analyses, e.g.* [*Figures 7, 8, 9 and 10*](#fig7 fig8 fig9 fig10){ref-type="fig"}.

We now include statistical analyses in these figure legends. Particularly, for luciferase assays, Student t-test was used in our analysis and the P values are included. For whole embryo phenotypes, at least two independent experiments were performed, with total numbers of embryos being indicated.

*4) The data presented in* [*Figure 9I*](#fig9){ref-type="fig"} *lacks several controls. The authors need to include "uninjected" and "xDsh alone"*.

These injections are included in [Figure 9I](#fig9){ref-type="fig"}.

*5) Some biological assays in a real in vivo/genetic setting (mouse or* Drosophila*) would have been helpful. The* Xenopus *experiments suffer from massive overexpression and pure gain-of-function approaches. Does the model hold up in a loss-of-function genetic context?*

We truly believe that the model we proposed should hold up in different loss-of-function genetic contexts. However, we will not be able to perform these studies in a very limited time frame and we also think that the experiments are out of the scope of this manuscript. Nevertheless, we plan to carry out some of the studies along those lines in the future.
